Difference between revisions of "IHERO Electronic Patient Record"

Revision as of 07:43, 18 January 2008

If you're interested, please add your name and contact info.

Colin Field, Medical Physicist
- Cross Cancer Institute, Edmonton, AB, Canada
- email: cfield@cancerboard.ab.ca
- phone: 780-432-8625
Mahmoud M. EL-GANTIRY,Radiation Oncologist,
- National Cancer Institute – Cairo University, Kasr EL-Aini street, Kornish El-Nil, Fom El-Khalig, 11796, Cairo, Egypt.
- Cellular Tel: +2-0101799845.
- Fax: +202-23635083.
- e-mail: melgantiry@yahoo.com
Andrew Miller, Radiation Oncologist
- Illawarra Cancer Care Centre, Wollongong, NSW 2500 Australia.
- email: alexisandrew@gmail.com
- phone: +61409654239

Knowledge Representation of data elements has to match oncological thought
- calls for a diagnosis/time based approach to data where sequencing and reasoning is preserved

Demographics
- need a way to use demographics to produce a unique ID to produce anonymous records if transferred
Diagnosis
- utilizing a structure which is mapped (via UMLS)
  - presently
    - using ICD .... 9 (USA) 10 (AU, NZ, UK?)
    - predominantly for malignant diagnosis alone
    - already includes structured morphology nomenclature (e.g. SNOMED
  - FUTURE
    - include all benign diagnoses (these are likely to be be transferrable from other specialties and GPs)
    - expanded morphology descriptors that include immunohistochemical patterns, genetic changes
Stage
- utilizing a structure which is mapped (via UMLS)
  - presently we use AJCC/UICC
  - in the future
    - utilizing more specific anatomical definitions
      - derived from CT/MRI/PET anatomy (?DICOM-SR subset)
      - described in an Anatomical Ontology
Intent of Oncological Plan
Employed Modalities
Modality Details

@@ Line 22: / Line 22: @@
 ==Required Data Elements==
-*
+* Knowledge Representation of data elements has to match oncological thought
+** calls for a diagnosis/time based approach to data where sequencing and reasoning is preserved
+------
+* Demographics
+** need a way to use demographics to produce a unique ID to produce anonymous records if transferred
+* Diagnosis
+** utilizing a structure which is mapped (via [http://umlsinfo.nlm.nih.gov/ UMLS])
+*** presently
+**** using ICD .... 9 (USA) 10 (AU, NZ, UK?)
+**** predominantly for malignant diagnosis alone
+**** already includes structured morphology nomenclature (e.g. [http://www.ihtsdo.org/our-standards/snomed-ct/ SNOMED]
+*** FUTURE
+**** include all benign diagnoses (these are likely to be be transferrable from other specialties and GPs)
+**** expanded morphology descriptors that include immunohistochemical patterns, genetic changes
+* Stage
+** utilizing a structure which is mapped (via [http://umlsinfo.nlm.nih.gov/ UMLS])
+*** presently we use AJCC/UICC
+*** in the future
+**** utilizing more specific anatomical definitions
+***** derived from CT/MRI/PET anatomy (?DICOM-SR subset)
+***** described in an [http://sig.biostr.washington.edu/projects/fm/AboutFM.html Anatomical Ontology]
+* Intent of Oncological Plan
+* Employed Modalities
+* Modality Details